跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,111 条关于
“reward pathways”
全部
7,111
临床试验
2,391
药物
61
机构
45
资讯
4,614
去年
Experimental Medication Shows Promise in Treating Cocaine Addiction
去年
Novo Nordisk Explores GLP-1 Drugs' Potential in Addiction Treatment
去年
CBD Reduces Alcohol Cravings and Brain Reward Center Activity in AUD Patients
去年
Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Suggests
去年
GLP-1 Agonists Show Promise in Addiction Treatment: Beyond Weight Loss
8个月前
GLP-1 Weight Loss Drugs Show Promise for Addiction Treatment in Early Clinical Studies
去年
Eli Lilly to Explore Zepbound for Alcohol and Drug Addiction Treatment
去年
GLP-1 Drug Semaglutide Shows Promise in Alcohol Addiction Treatment Study at CU
去年
FDA Approves Second Manufacturing Site for CONTRAVE, Bolstering Supply Chain for Leading Oral Weight Loss Medication
3个月前
Novel Gut-Brain Drug Nezavist Shows Promise for Alcohol Use Disorder, Enters Phase 1 Trials
第 1 页,共 462 页
上一页
下一页